Oral insulin capsule developer Oramed Pharmaceuticals Inc. (Bulletin Board:ORMP.OB); DAX: OJU) has been selected for the first Presidential conference, “Facing Tomorrow,” as one of the 60 “enterprises of tomorrow”.
The event, from May 13 through 15, is being held to mark the country’s sixtieth birthday.
Jerusalem-based Oramed was also one of six companies chosen to be featured in a video presentation at the conference’s opening event.
The conference will be attended by global political and business leaders, including Israeli Prime Minister Ehud Olmert, President George W. Bush, and Google founder Sergey Brin.
“The selection of Oramed as one of the companies to change the face of tomorrow is a great honor,” said Oramed CEO Nadav Kidron. “Being chosen for the conference illustrates the potential of our technology to make a significant difference for millions of diabetics around the world.”
Oramed Pharmaceuticals is an Israeli-based company focused on the development of oral delivery solutions based on proprietary technology. Oramed is currently developing an orally ingestible insulin capsule for the treatment of diabetes. The company is also pursuing the development of oral delivery solutions for drugs and vaccines presently delivered via injection.
Published by Globes [online], Israel business news - www.globes-online.com - on May 8, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008